News
Eric Green, M.D., Ph.D., formerly the NHGRI director, has been awarded by Fierce Pharma as a Fierce 50 Innovation Honoree. The Fierce 50 is designed to honor the 50 most influential leaders and organizations shaping the future of biopharma, healthcare, and life sciences. The Fierce editorial team
Are you an MBA student interested in working with federal labs such as the NIH? You will want to attend the next Federal Lab Consortium (FLC) webinar on the Federal Lab Education Accelerator (FLEX) Program. This program helps connect entrepreneurial students in MBA programs with federal labs’
Inventors at the National Cancer Institute (NCI) and The National Institute of Allergy and Infectious Diseases (NIAID) have developed and isolated six nanobodies to be used in therapeutics against and diagnostics of the Lassa virus (LASV). LASV is highly prevalent in West Africa and has high
Sharing U.S. Government COVID-19 vaccine-related intellectual property and research tools for greater global access. Through the National Institutes of Health (NIH), the United States has recently licensed the intellectual property and research tools for several COVID-19 technologies to the